Albareda MC, Olivera GC, Laucella SA, Alvarez MG, Fernandez ER, Lococo B, Viotti R, Tarleton RL, Postan M. Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J Immunol. 2009 Sep 15;183(6):4103-8.
Cutrullis RA, Postan M, Petray PB, Corral RS. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Pathobiology. 2009;76(4):170-80. Epub 2009 Jun 29.
De Rissio AM, Scollo K, Cardoni RL. [Maternal-fetal transmission of Trypanosoma cruzi in Argentina] Medicina (B Aires). 2009;69(5):529-35.
Duschak VG, Couto AS Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem. 2009;16(24):3174-202.
Laucella SA., Perez Mazliah D, Bertocchi G, Alvarez MG., Cooley G, Viotti R, Albareda MC, Lococo B, Postan M, Armenti A, Tarleton RL. Changes in Trypanosoma cruzi –Specic Immune Responses after Treatment: Surrogate Markers of Treatment Eficacy. Clin Infect Dis. 2009 Dec 1;49(11):1675-84.
Segura EL, Torres AG, Fusco O, García BA. Mitochondrial 16S DNA variation in populations of Triatoma infestans from Argentina. Med Vet Entomol. 2009 Mar;23(1):34-40.
Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection. Parasitology. 2009 May;136(6):627-39. Epub 2009 Apr 14
Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7.
Sosa-Estani S, Viotti R, Segura EL. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):167-80.
Tekiel V, Alba-Soto CD, González Cappa SM, Postan M, Sánchez DO. Identification of novel vaccine candidates for Chagas’ disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009 Feb 25;27(9):1323-32. Epub 2009 Jan 20 de Rissio AM, Scollo K, Cardoni RL. Maternal-fetal transmission of Trypanosoma cruzi in Argentina. Medicina (B Aires).2009;69(5):529-35
Cutrullis RA, Postan M, Petray PB, Corral RS. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.Pathobiology. 2009;76(4):170-80. Epub 2009 Jun 29.
Duschak VG, Couto AS Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem. 2009;16(24):3174-20
Tekiel V, Alba-Soto CD, González Cappa SM, Postan M, Sánchez DO. Identification of novel vaccine candidates for Chagas’ disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009 Feb 25;27(9):1323-32. Epub 2009 J
De Rissio Ana María; Riarte Adelina Rosa; García Miriam Martín; Esteva Mónica Inés; Quaglino Marta; Ruiz Andrés Mariano. Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am. J. Trop. Med. Hyg., 82(5), 2010, pp. 838–845.
Albareda María Cecilia; Olivera Gabriela Carina; De Rissio Ana María; Postan Miriam
Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.
Am. J. Trop. Med. Hyg., 82(5), 2010, pp. 861–864.
Andrzej Galat, Jacqueline Búa. Molecular aspects of cyclophilins mediating therapeutic actions of their ligands. Cell. Mol. Life Sci. (2010) 67:3467–3488.
Vilma G. Duschak and Alicia S. Couto. Targets and Patented Drugs for Chemotherapy of
Chagas Disease. Frontiers in Anti-Infective Drug Discovery, 2010, (1), 323-408 323.
Patricia A. Garavagliaa, Joaquín J.B. Cannatab,c, Andrés M. Ruiza, Dante Maugeric, Rosario Durand, Mónica Galleanoe, Gabriela A. García. Identification, cloning and characterization of an aldo-keto reductase from Trypanosoma cruzi with quinone oxido-reductase activity. Molecular & Biochemical Parasitology 173 (2010) 132–141.
Noelia L. Grosso, Jacqueline Búa, Alina E. Perrone, Mariela N. Gonzalez, Patricia L. Bustos, Miriam Postan, Laura E. Fichera. Trypanosoma cruzi: Biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs. Exp. Parasitotol. 126 (2010) 239–244.
Olivera GC, Albareda MC, Alvarez MG, De Rissio AM, Fichera LE, Cooley G, Yachelini P, Hrellac HA, Riboldi H, Laucella SA, Tarleton RL, Postan M. Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina.. Microbes and Infection 12 (2010) 359-363.
Mallimaci MC, Sosa-Estani S, Russomando G, Sanchez Z, Sijvarger C, Alvarez IM, Barrionuevo L, Lopez C, Segura EL.Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina.
Am J Trop Med Hyg. 2010.82(1):55-9.
Montanari J, Maidana C, Esteva MI, Salomon C, Morilla MJ, Romero EL.Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. J Control Release. 2010;147(3):368-76.
Cazorla SI, Frank FM, Becker PD, Arnaiz M, Mirkin GA, Corral RS, Guzmán CA, Malchiodi EL.Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection. J Infect Dis. 2010;202(1):136-44.
Chagas disease and Solid Organ Transplantation. The Chagas’ Disease Argentine Collaborative Transplant Consortium and Domingo Casadei. Transplantation Proceedings, 42, 3354–3359, 2010.
Zocratto KB, Osimani ML, Peralta LM, Latorre L, Muzzio E, Segura M, Chiparelli H, Proietti FA, Rey J, Vazquez E, Cuchi P, Sosa-Estani S, Rossi D, Weissenbacher M, Caiaffa WT Sexual behavior and HBV infection among noninjecting cocaine users (NICUs). Subst Use Misuse. 2010 Oct; 45(12):2026-44
